// App-Quantinova.ai

: 1R Pathway in Idiopathic Pulmonary Fibrosis

Researchers

Presenter

  • M. S. Espindola

Principal Investigators

  • D. M. Habiel

  • Y. A. P. J. Sa

  • M. Hohmann

  • I. C. Jones

  • A. Coelho

  • C. M. Hogaboam

Medical Centers

  • Medicine/ Rheumatology, Cedar Sinai Medical Center, Los Angeles, United States

  • Cedars-Sinai, Los Angeles, California, United States

  • Medicine/ Rheumatology, Cedar Sinai Medical Center, Los Angeles, United States

  • Pulmonary Division, Cedars-Sinai Medical Center, Los Angeles, CA, United States,

  • Medicine/ Rheumatology, Cedar Sinai Medical Center, Los Angeles, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Idiopathic pulmonary fibrosis

Biomarkers

  • Insulin-like growth factor 1 receptor

Drug/Treatment

  • AEW541

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved